Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge.
about
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.CD40 engagement on dendritic cells, but not on B or T cells, is required for long-term control of murine gammaherpesvirus 68.Collaboration between tumor-specific CD4+ T cells and B cells in anti-cancer immunity.5,6-Dimethylxanthenone-4-acetic acid treatment of a non-immunogenic tumour does not synergize with active or passive CD8+ T-cell immunotherapy.The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity.Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma.Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help.Inefficient boosting of antitumor CD8(+) T cells by dendritic-cell vaccines is rescued by restricting T-cell cytotoxic functions.
P2860
Q36491182-D8CE86A6-DDC5-440C-B1DC-14BA807EE7EDQ36949825-E9CA1B82-2EB4-4434-AFFB-6A9F1D07B09EQ37327460-B81CB3B4-0AF8-4C7F-B584-CF1D0F4653B7Q40256708-4950B83A-813A-4760-B1AC-0330B1E4CE9CQ40411751-B8FD7208-7508-44F5-8707-7D18739B497DQ41468156-F9372C75-1043-4894-A4AF-317A3FC2B39CQ41827708-EBDA13AC-F985-450E-B21B-A9F2DEA2F7ABQ42417553-BB95D318-772B-40CE-94EE-DACD68984D2D
P2860
Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Tumor-peptide-pulsed dendritic ...... ction against tumor challenge.
@en
Tumor-peptide-pulsed dendritic ...... ction against tumor challenge.
@nl
type
label
Tumor-peptide-pulsed dendritic ...... ction against tumor challenge.
@en
Tumor-peptide-pulsed dendritic ...... ction against tumor challenge.
@nl
prefLabel
Tumor-peptide-pulsed dendritic ...... ction against tumor challenge.
@en
Tumor-peptide-pulsed dendritic ...... ction against tumor challenge.
@nl
P2093
P356
P1476
Tumor-peptide-pulsed dendritic ...... ection against tumor challenge
@en
P2093
F Ronchese
P Moroni-Rawson
P2888
P304
P356
10.1007/S002620050392
P577
1997-08-01T00:00:00Z